News
The Nasdaq Biotechnology Index closed up over 2.9%, with component stock Theravance BioPharma rising 22.55%, Edgewise Therapeutics up 17.51%, uniQure NV up 17.48%, and Autolus Therapeutics up 14.39% in fourth place. Pyxis Oncology, on the other hand, fell 4.19%, ranking third from the bottom, followed by Humacyte down 5.19% and Olema down 5.86%
Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments